Chemical Features Important for Activity in a Class of Inhibitors Targeting the Wip1 Flap Subdomain
Harichandra D Tagad1, Subrata Debnath1, Victor Clausse2
1Laboratory of Cell Biology, National Cancer Institute, US National Institutes of Health, Bethesda, MD, 20892, USA.
Abstract:
The wild-type p53 induced phosphatase 1, Wip1 (PP2Cδ), is a protein phosphatase 2C (PP2C) family serine/threonine phosphatase that negatively regulates the function of the tumor suppressor p53 and several of its positive regulators such as ATM, Chk1, Chk2, Mdm2, and p38 MAPK. Wip1 dephosphorylates and inactivates its protein targets, which are critical for cellular stress responses. Additionally, Wip1 is frequently amplified and overexpressed in several human cancer types. Because of its negative role in regulating the function of tumor suppressor proteins, Wip1 has been identified as a potential therapeutic target in various types of cancers. Based on a recently reported Wip1 inhibitor (G-1), we performed an extensive structure-activity relationship (SAR) analysis. This led us to interesting findings in SAR trends and to the discovery of new chemical analogues with good specificity and bioavailability.
Insights
Wild-type p53 induced phosphatase 1 (Wip1) negatively regulates tumor suppressors. Researchers analyzed Wip1 inhibitors, discovering new analogues with improved specificity and bioavailability for cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Wip1 (PP2Cδ) is a serine/threonine phosphatase that negatively regulates tumor suppressor p53 and its activators.
- Wip1 dephosphorylates key proteins in cellular stress responses.
- Wip1 is overexpressed in many human cancers, making it a therapeutic target.
Purpose of the Study:
- To conduct a structure-activity relationship (SAR) analysis of a Wip1 inhibitor (G-1).
- To identify novel Wip1 chemical analogues with enhanced specificity and bioavailability.
Main Methods:
- Extensive structure-activity relationship (SAR) analysis.
- Chemical synthesis and characterization of Wip1 analogues.
Main Results:
- Identified key SAR trends for Wip1 inhibition.
- Discovered novel chemical analogues of G-1 with potent Wip1 inhibitory activity.
- Demonstrated good specificity and bioavailability for the new analogues.
Conclusions:
- Wip1 is a viable therapeutic target in cancer.
- The SAR analysis provides a foundation for developing Wip1-targeted cancer therapies.
- Novel Wip1 inhibitors with improved pharmacological properties were discovered.
More Related Videos
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Thermodynamics: Chemical Potential and Activity
The thermodynamic equilibrium constant is more accurately defined in terms of activity rather than concentration.
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Drug Classes and Categories
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Chemical Formulas
Chemical Equations
